Analysis using Oncomine, a cancer-specific bioinformatics database, found RAMP1 to be significantly upregulated in prostate cancer when compared with other cancers including the breast, bladder, liver, lung and pancreatic (P = 6.36 × 10−47). Here, RAMP1 is linked to prostate cancer.